Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

1.44
Delayed Data
As of Dec 09
 +0.08 / +5.88%
Today’s Change
0.84
Today|||52-Week Range
8.16
-81.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$67.6M

Company Description

Infinity Pharmaceuticals, Inc. is an innovative drug discovery and development company, which engages in discovering, developing and delivering medicines for difficult-to-treat diseases, developing novel small molecule drugs that target emerging disease pathways. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.

Contact Information

Infinity Pharmaceuticals, Inc.
784 Memorial Drive
Cambridge Massachusetts 02139
P:(617) 453-1000
Investor Relations:
(617) 453-1336

Employees

Shareholders

Other institutional51.86%
Individual stakeholders31.22%
Mutual fund holders30.50%

Top Executives

Adelene Q. PerkinsChairman, President & Chief Executive Officer
Lawrence E. BlochExecutive VP, Chief Financial & Business Officer
Julian AdamsPresident-Research & Development
Sujay KangoChief Commercial Officer & Executive VP
Seth TaskerSecretary, Vice President & General Counsel